139 related articles for article (PubMed ID: 38777581)
1. Risk of hypersensitivity pneumonitis and other interstitial lung diseases following organic dust exposure.
Iversen IB; Vestergaard JM; Basinas I; Ohlander J; Peters S; Bendstrup E; Bonde JPE; Schlünssen V; Rasmussen F; Stokholm ZA; Andersen MB; Kromhout H; Kolstad HA
Thorax; 2024 May; ():. PubMed ID: 38777581
[TBL] [Abstract][Full Text] [Related]
2. Risk of hypersensitivity pneumonitis and interstitial lung diseases among pigeon breeders.
Cramer C; Schlünssen V; Bendstrup E; Stokholm ZA; Vestergaard JM; Frydenberg M; Kolstad HA
Eur Respir J; 2016 Sep; 48(3):818-25. PubMed ID: 27230447
[TBL] [Abstract][Full Text] [Related]
3. A nationwide follow-up study of occupational organic dust exposure and risk of chronic obstructive pulmonary disease (COPD).
Vested A; Basinas I; Burdorf A; Elholm G; Heederik DJJ; Jacobsen GH; Kolstad HA; Kromhout H; Omland Ø; Sigsgaard T; Thulstrup AM; Toft G; Vestergaard JM; Wouters IM; Schlünssen V
Occup Environ Med; 2019 Feb; 76(2):105-113. PubMed ID: 30598459
[TBL] [Abstract][Full Text] [Related]
4. Timber-colonizing gram-negative bacteria as potential causative agents of respiratory diseases in woodworkers.
Wójcik-Fatla A; Mackiewicz B; Sawczyn-Domańska A; Sroka J; Siwiec J; Paściak M; Szponar B; Pawlik K; Dutkiewicz J
Int Arch Occup Environ Health; 2022 Aug; 95(6):1179-1193. PubMed ID: 35015109
[TBL] [Abstract][Full Text] [Related]
5. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
[TBL] [Abstract][Full Text] [Related]
6. Occupational interstitial lung diseases.
Spagnolo P; Ryerson CJ; Guler S; Feary J; Churg A; Fontenot AP; Piciucchi S; Udwadia Z; Corte TJ; Wuyts WA; Johannson KA; Cottin V
J Intern Med; 2023 Dec; 294(6):798-815. PubMed ID: 37535448
[TBL] [Abstract][Full Text] [Related]
7. Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis.
Osaki M; Arai T; Sumikawa H; Takimoto T; Takeuchi N; Tamiya A; Okishio K; Inoue Y
Oncology; 2023; 101(5):303-312. PubMed ID: 36689929
[TBL] [Abstract][Full Text] [Related]
8. Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects.
Dhooria S; Sehgal IS; Agarwal R; Muthu V; Prasad KT; Kathirvel S; Garg M; Bal A; Aggarwal AN; Behera D
PLoS One; 2022; 17(7):e0271665. PubMed ID: 35862355
[TBL] [Abstract][Full Text] [Related]
9. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bioaerosol exposures during conditioning of biofilter organic media beds.
Barth E; Talbott N; Gable R; Richter S; Reponen T
Appl Occup Environ Hyg; 2002 Jan; 17(1):10-4. PubMed ID: 11800400
[TBL] [Abstract][Full Text] [Related]
11. Occupational exposure to eight organic dusts and respiratory cancer among Finns.
Laakkonen A; Kyyrönen P; Kauppinen T; Pukkala EI
Occup Environ Med; 2006 Nov; 63(11):726-33. PubMed ID: 16601013
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.
Olson AL; Patnaik P; Hartmann N; Bohn RL; Garry EM; Wallace L
Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606
[TBL] [Abstract][Full Text] [Related]
13. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
14. New-onset COPD and Decline in Lung Function Among Wood Dust-Exposed Workers: Re-analysis of a 6-year Follow-up Study.
Bolund ACS; Miller MR; Jacobsen GH; Sigsgaard T; Schlünssen V
Ann Work Expo Health; 2018 Nov; 62(9):1064-1076. PubMed ID: 30165410
[TBL] [Abstract][Full Text] [Related]
15. Organic dust toxic syndrome: an acute febrile reaction to organic dust exposure distinct from hypersensitivity pneumonitis.
Von Essen S; Robbins RA; Thompson AB; Rennard SI
J Toxicol Clin Toxicol; 1990; 28(4):389-420. PubMed ID: 2269997
[TBL] [Abstract][Full Text] [Related]
16. New trajectories in the treatment of interstitial lung disease: treat the disease or treat the underlying pattern?
Morisset J; Lee JS
Curr Opin Pulm Med; 2019 Sep; 25(5):442-449. PubMed ID: 31365378
[TBL] [Abstract][Full Text] [Related]
17. Interstitial lung diseases: an epidemiological overview.
Demedts M; Wells AU; Antó JM; Costabel U; Hubbard R; Cullinan P; Slabbynck H; Rizzato G; Poletti V; Verbeken EK; Thomeer MJ; Kokkarinen J; Dalphin JC; Taylor AN
Eur Respir J Suppl; 2001 Sep; 32():2s-16s. PubMed ID: 11816822
[TBL] [Abstract][Full Text] [Related]
18. Occupational exposure to organic dust increases lung cancer risk in the general population.
Peters S; Kromhout H; Olsson AC; Wichmann HE; Brüske I; Consonni D; Landi MT; Caporaso N; Siemiatycki J; Richiardi L; Mirabelli D; Simonato L; Gustavsson P; Plato N; Jöckel KH; Ahrens W; Pohlabeln H; Boffetta P; Brennan P; Zaridze D; Cassidy A; Lissowska J; Szeszenia-Dabrowska N; Rudnai P; Fabianova E; Forastiere F; Bencko V; Foretova L; Janout V; Stücker I; Dumitru RS; Benhamou S; Bueno-de-Mesquita B; Kendzia B; Pesch B; Straif K; Brüning T; Vermeulen R
Thorax; 2012 Feb; 67(2):111-6. PubMed ID: 21856697
[TBL] [Abstract][Full Text] [Related]
19. Scoping review of exposure questionnaires and surveys in interstitial lung disease.
Barnes H; Elmrayed S; Barber CM; Feary J; Lee CT; Gandhi S; Peters CE; Salisbury ML; Johannson KA
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754906
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries.
Hilberg O; Hoffmann-Vold AM; Smith V; Bouros D; Kilpeläinen M; Guiot J; Morais A; Clemente S; Daniil Z; Papakosta D; Fretheim H; Neves S; Alfaro TM; Antoniou KM; Valveny N; Asijee G; Soulard S; Wuyts W
ERJ Open Res; 2022 Jan; 8(1):. PubMed ID: 35083316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
